pe
pep-05400 v1 CC-BY-SA-4.0

Viral envelope gp160 HIV-blocking peptide

An experimental antiviral peptide studied for its ability to block HIV; not an approved drug and used only in laboratory research.

statuscomputed targetANTIMICROBIAL length48 aa refs1
anti-hivantiviral
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.757
avg pLDDT97.2
ranking score0.929
STRUCTURE · PEP-05400 × ANTIMICROBIAL
ranking0.929
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence48 aa
15101520253035404548
IKKEIEAIKKEQEAIK KKIEAIEKEIEAQQHL LQLTVWGIKQLQARIL
in the news 6 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.9289454817771912 boltz-2
3-letter notation
Ile-Lys-Lys-Glu-Ile-Glu-Ala-Ile-Lys-Lys-Glu-Gln-Glu-Ala-Ile-Lys-Lys-Lys-Ile-Glu-Ala-Ile-Glu-Lys-Glu-Ile-Glu-Ala-Gln-Gln-His-Leu-Leu-Gln-Leu-Thr-Val-Trp-Gly-Ile-Lys-Gln-Leu-Gln-Ala-Arg-Ile-Leu
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Viral envelope gp160 HIV-blocking peptide (pep-05400, v1). PeptideModel. https://peptidemodel.com/card/pep-05400
@peptide{pep05400,
  sequence = {IKKEIEAIKKEQEAIKKKIEAIEKEIEAQQHLLQLTVWGIKQLQARIL},
  target   = {antimicrobial},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 1 by signal overlap
references 1 papers
[1]
Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region
Eckert D; Kim P Proceedings of the National Academy of Sciences 2001
source scaffold
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use